RESEARCH PAPER
Asbestosis hospitalizations in Poland (2006–2016): results from the National Hospital Discharge Registry
 
More details
Hide details
1
Department of Social Medicine and Public Heath, Medical University, Warsaw, Poland
2
Institute of Rural Health, Lublin, Poland
3
National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland
4
Faculty of Law and Administration, Kazimierz Pułaski University of Technology and Humanities in Radom, Poland
CORRESPONDING AUTHOR
Krzysztof Kanecki   

Medical University of Warsaw, Oczki 3, 02-007, Warszawa, Poland
 
Ann Agric Environ Med. 2020;27(2):284–289
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Occupational asbestos exposure is one of the major public health issues. Although asbestos use in Poland has decreased, asbestosis continues to remain an important health concern in the area of occupational medicine. The aim of the study is to perform a descriptive analysis of hospitalization cases in patients suffering from asbestosis in Poland.

Material and methods:
The authors used hospital discharge records to conduct a retrospective, population-based study. To estimate the asbestosis hospitalization rate, data from the Nationwide General Hospital Morbidity Study conducted by the National Institute of Public Health were used. Events were defined as in-patient hospital discharges during 2006–2016. 1,101 hospitalization records of 764 patients were included in the study.

Results:
In the study group of first-time hospitalized patients, the mean and median ages were 68.1 and 69 years, respectively; CI: 67.3–68.9; SD: 11.1, min-max:16–99 years. In this group, significant gender differences were observed (560 males vs. 204 female; P<0.001). No statistical differences were observed regarding the place of residence. During the observation period, 61 in-hospital deaths were reported (8% of all patients), 40 of whom (5.2 % of all patients) took place during the first-time hospitalizations. Asbestosis hospitalizations were mainly clustered in the south-western region, whereas the highest hospitalization rates were clustered in several areas of Poland.

Conclusions:
The authors believe this study to be the first evaluation of asbestosis in Poland made on the basis of the hospital morbidity database. The data presented may be helpful in comparative studies on the epidemiology of asbestosis across European countries.

 
REFERENCES (40)
1.
Virta RL, US Geological Survey (USGS). Worldwide Asbestos Supply and Consumption Trends from 1990 through 2003: U.S. Geological Survey Circular 1298. Reston, United States: US Geological Survey (USGS). 2006. Available at https://pubs.usgs.gov/circ/200... (access: 2020.04.01).
 
2.
The World Health Organization. Asbestos: Elimination of Asbestos-related Diseases. Available at: https://www.who.int/news-room/... (access: 2019.05.12).
 
3.
Dang GTT, Barros N, Higgins SA, Langley RL, Lipton D. Descriptive review of asbestosis and silicosis hospitalization trends in North Carolina, 2002–2011. N C Med J. 2013; 74(5): 368–375.
 
4.
Davis C, Vijaykumar J, Lackovic M, Diaz JH. Asbestosis in Louisiana: a descriptive review and demographic analysis of hospitalizations for abestosis, 1999–2009. J La State Med Soc. 2011; 163(6): 336–341.
 
5.
Naik SL, Lewin M, Young R, Dearwent SM, Lee R. Mortality from asbestos-associated disease in Libby, Montana 1979–2011. J Expo Sci Environ Epidemiol. 2017; 27(2): 207–213. DOI: 10.1038/jes.2016.18.
 
6.
Ferrante P. Asbestosis and silicosis hospitalizations in Italy (2001–2015): results from the National Hospital Discharge Registry. Eur J Public Health. 2019; 29(5): 876–882. DOI: 10.1093/eurpub/ckz003.
 
7.
García Gómez M, Menéndez-Navarro A, Castañeda López R. [Incidence of asbestosis and other benign lung diseases: Spain, 1962–2010]. Rev Esp Salud Publica. 2012; 86(6): 613–25. DOI: 10.4321/S1135-57272012000600007.
 
8.
Baur X. Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation. Int J Environ Res Public Health. 2018; 15(1): E143. DOI: 10.3390/ijerph15010143.
 
9.
World Health Organization (WHO). The Human and Financial Burden of Asbestos in the WHO European Region. Meeting Report, Bonn, Germany; WHO Regional Office for Europe: Copenhagen, Denmark, 2012. Available at: http://www.euro.who.int/__data.... (access: 2019.05.19).
 
10.
Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health. 2013; 34: 205–216. DOI: 10.1146/annurev-publhealth-031811-124704.
 
11.
Virta RL, Flanagan DM. Asbestos. In: U.S. Geological Survey. Minerals Yearbook 2014. Available at https://www.usgs.gov/centers/n... (access: 2020.02.05).
 
12.
Szubert Z, Stankiewicz-Choroszucha B, Wrońska-Sobolewska M, Siewierska H, Kosińska M, Borys W, et al. [Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000–2004]. Med Pr. 2006; 57(2): 101–108.
 
13.
Szeszenia-Dabrowska N. [Asbestos as a risk factor for pulmonary diseases]. Prz Lek. 2008; 65 Suppl 2: 26–34.
 
14.
Krówczyńska M, Wilk E. Spatial analysis of asbestos exposure and occupational health care in Poland during the period 2004–2013. Geospat Health. 2018; 13(2). DOI: 10.4081/gh.2018.689.
 
15.
Szeszenia-Dąbrowska N, Świątkowska B, Sobala W, Szubert Z, Wilczyńska U. Asbestos related diseases among workers of asbestos processing plants in relation to type of production and asbestos use. Med Pr. 2015; 66(1): 1–9.
 
16.
Statistics Poland. http://stat.gov.pl. (access: 2018.07.30).
 
17.
TIBCO Software Inc. (2017). Statistica (data analysis software system), version 13. http://statistica.io.
 
18.
Abramson, J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations 2011, 8:1.
 
19.
Visonà SD, Villani S, Manzoni F, Chen Y, Ardissino G, Russo F, et al. Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy). J Public Health Res. 2018; 7(3): 1519. DOI: 10.4081/jphr.2018.1519.
 
20.
Rosell-Murphy MI, Abós-Herràndiz R, Olivella JT, Alberti-Casas C, Allas IG, Artés XM, et al. Risk factors associated with asbestos-related diseases: a community-based case–control study. BMC Public Health. 2013; 13: 723.
 
21.
Villanueva Ballester V, Damiá Iborra M, Esteban Buedo V. [Data completeness in the Spanish official medical record for asbestos-exposed workers]. [Article in Catalan, Spanish] Arch Prev Riesgos Labor. 2013 Jun;16(2):77–86. DOI: 10.12961/aprl. 2012.16.2.03.
 
22.
Bledsoe JR, Christiani DC, Kradin RL. Smoking-associated fibrosis and pulmonary asbestosis. Int J Chron Obstruct Pulmon Dis. 2014; 10: 31–37. DOI: 10.2147/COPD.S74643.
 
23.
Magnani C, Ancona L, Baldassarre A, Bressan V, Cena T, Chellini E, et al. [Time trend in mesothelioma and lung cancer risk in asbestos workers in Italy]. [Article in Italian] Epidemiol Prev. 2016; 40(1 Suppl 1): 64–67.
 
24.
Mándi A, Posgay M, Vadász P, Major K, Rödelsperger K, Tossavainen A, et al. Role of occupational asbestos exposure in Hungarian lung cancer patients. Int Arch Occup Environ Health. 2000; 73(8): 555–560. DOI: 10.1007/s004200000172.
 
25.
Everatt RP, Smolianskiene G, Tossavainen A, Cicenas S, Jankauskas R. Occupational asbestos exposure among respiratory cancer patients in Lithuania. Am J Ind Med. 2007; 50(6): 455–463. DOI: 10.1002/ajim.20467.
 
26.
Liu MX, Zhu XJ, Li T, Xiao P, Wang D. [Exploratory analysis on burden of disease attributable to asbestosis from 2006 to 2015]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2017; 35(6): 429–432. DOI: 10.3760/cma.j.issn.1001–9391.2017.06.007.
 
27.
Song PP, Wang Y, Sun JL, Gao Y, Liu J, Chen YX. [The incidence of asbestos-related diseases about on asbestos enterprises in Qingdao from 1988 to 2014]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016; 34(3): 203–205. DOI: 10.3760/cma.j.issn.1001-9391.2016.03.010.
 
28.
Carder M, Darnton A, Gittins M, Stocks SJ, Ross D, Barber CM, et al. Chest physician-reported, work-related, long-latency respiratory disease in Great Britain. Eur Respir J. 2017; 50(6): 1700961. DOI: 10.1183/13993003.00961-2017.
 
29.
Adib G, Labrèche F, De Guire L, Dion C, Dufresne A. Short, fine and WHO asbestos fibers in the lungs of quebec workers with an asbestos-related disease. Am J Ind Med. 2013; 56(9): 1001–1014.
 
30.
Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park EK, et al. Asbestos: use, bans and disease burden in Europe. Bull World Health Organ. 2014; 92(11): 790–797. DOI: 10.2471/BLT.13.132118.
 
31.
Harding AH, Darnton A, Wegerdt J, McElvenny D. Mortality among British asbestos workers undergoing regular medical examinations (1971–2005). Occup Environ Med. 2009; 66(7): 487–495. DOI: 10.1136/oem.2008.043414.
 
32.
Parolari G. An outbreak of cancer and asbestosis among former amosite-exposed subjects in Ledro Valley, Italy. From discovery to environmental cleanup. Ann Ist Super Sanita. 2019; 55(1): 80–89. DOI: 10.4415/ANN_19_01_15.
 
33.
Antao VC dos S, Pinheiro GA, Wassell JT. Asbestosis mortality in the USA: facts and predictions. Occup Environ Med. 2009; 66(5): 335–338. DOI: 10.1136/oem.2008.039172.
 
34.
EWG New Estimate Finds Asbestos Kills 12,000–15,000 Americans a Year. Available online: http://www.asbestosnation.org/... (access: 2019.05.12).
 
35.
Harding A-H, Darnton AJ. Asbestosis and mesothelioma among British asbestos workers (1971–2005). Am J Ind Med. 2010; 53(11): 1070–1080. DOI: 10.1002/ajim.20844.
 
36.
Hanley A, Hubbard RB, Navaratnam V. Mortality trends in asbestosis, extrinsic allergic alveolitis and sarcoidosis in England and Wales. Respir Med. 2011; 105(9): 1373–1379. DOI: 10.1016/j.rmed.2011.05.008.
 
37.
Darnton A, Hodgson J, Benson P, Coggon D. Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond). 2012; 62(7): 549–552. DOI: 10.1093/occmed/kqs119.
 
38.
Farioli A, Violante FS, La Vecchia C, Negri E, Pelucchi C, Spatari G, et al. Temporal Patterns of Exposure to Asbestos and Risk of Asbestosis: An Analysis of a Cohort of Asbestos Textile Workers. J Occup Environ Med. 2018; 60(6): 536–541. DOI: 10.1097/JOM.0000000000001260.
 
39.
Kang DM, Kim JE, Kim YK, Lee HH, Kim SY. Occupational Burden of Asbestos-Related Diseases in Korea, 1998–2013: Asbestosis, Mesothelioma, Lung Cancer, Laryngeal Cancer, and Ovarian Cancer. J Korean Med Sci. 2018; 33(35): e226. DOI: 10.3346/jkms.2018.33.e226.
 
40.
Takahashi K, Landrigan PJ, Collegium Ramazzini. The Global Health Dimensions of Asbestos and Asbestos-Related Diseases. Ann Glob Health. 2016; 82(1): 209–213. DOI: 10.1016/j.aogh.2016.01.019.
 
eISSN:1898-2263
ISSN:1232-1966